European Journal of Cancer
Volume 42, Issue 15 , Pages 2433-2453 , October 2006

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

  • M.S. Aapro

      Affiliations

    • Multidisciplinary Oncology Institute, Clinique de Genolier, 1, route du Muids, 1272 Genolier, Switzerland
    • Corresponding Author InformationCorresponding author: Tel.: +41 22 366 9106; fax: +41 22 366 9131.
    • Member of the EORTC Board and Chair of the EORTC Task Force Elderly.
    • ,
  • D.A. Cameron

      Affiliations

    • Department of Oncology, University of Edinburgh and Western General Hospital, Edinburgh, Scotland
    • Representative of the EORTC Breast Cancer Group.
    • ,
  • R. Pettengell

      Affiliations

    • Department of Haematology, St George’s Hospital, University of London, London, UK
    • Member of the EORTC and Lymphoma Expert.
    • ,
  • J. Bohlius

      Affiliations

    • Department I of Internal Medicine, University of Cologne, Cologne, Germany
    • Methodology Expert.
    • ,
  • J. Crawford

      Affiliations

    • Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC, USA
    • Member of MASCC (Multinational Association for Supportive Care in Cancer) and US Expert.
    • ,
  • M. Ellis

      Affiliations

    • UAE University, Faculty of Medicine and Health Sciences, Abu Dhabi, United Arab Emirates
    • Member of the EORTC Infectious Diseases Group.
    • ,
  • N. Kearney

      Affiliations

    • Cancer Care Research Centre, Department of Nursing and Midwifery, University of Stirling, Stirling, UK
    • Nursing Expert, mandated by EONS (European Oncology Nursing Society).
    • ,
  • G.H. Lyman

      Affiliations

    • James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    • US Expert.
    • ,
  • V.C. Tjan-Heijnen

      Affiliations

    • Radboud University Nijmegen, Department of Medical Oncology, Nijmegen, The Netherlands
    • Representative of the EORTC Lung Cancer Group.
    • ,
  • J. Walewski

      Affiliations

    • The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
    • Representative of the EORTC Lymphoma Group.
    • ,
  • D.C. Weber

      Affiliations

    • Department of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
    • Representative of the EORTC Radiation Therapy Group.
    • ,
  • C. Zielinski

      Affiliations

    • Clinical Division of Oncology, Department of Medicine I, University Hospital, Central European Cooperative Oncology Group, Vienna, Austria
    • Breast Cancer Expert and Representative of CECOG (Central European Cooperative Oncology Group).
    • ,
  • European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party

Received 16 May 2006 ,Accepted 16 May 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(06)00391-1

doi: 10.1016/j.ejca.2006.05.002

European Journal of Cancer
Volume 42, Issue 15 , Pages 2433-2453 , October 2006

Article Tools

* Image Usage & Resolution